Reinhold Europe AB (publ) (WSE:RHD)

Regulus Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2019	FY 2018	FY 2017	FY 2016	FY 2014
Period Ending	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2014
Cash & Equivalents	-	-	0.01	-	0.26
Cash & Short-Term Investments	-	-	0.01	-	0.26
Cash Growth	-	-	-	-	102065.60%
Accounts Receivable	-	-	-	-	0.67
Other Receivables	-	0.51	0.32	0.05	0.15
Receivables	-	0.51	0.32	0.05	0.81
Prepaid Expenses	-	-	0.09	-	-
Total Current Assets	-	0.51	0.41	0.05	1.07
Property, Plant & Equipment	-	-	1.41	-	1.92
Goodwill	-	-	1.64	-	3.23
Other Intangible Assets	-	-	-	-	7.62
Long-Term Deferred Tax Assets	-	-	-	-	0
Other Long-Term Assets	0.92	1.66	0.33	-	8.32
Total Assets	0.92	2.17	3.8	0.05	22.17
Accounts Payable	0.22	0.69	0.52	-	0.26
Accrued Expenses	-	0.38	0.29	0.07	0.52
Short-Term Debt	-	-	-	-	0.53
Current Income Taxes Payable	1.03	1.07	1.05	-	-
Other Current Liabilities	0.36	0.65	2.97	1.02	0.76
Total Current Liabilities	1.61	2.78	4.83	1.09	2.06
Long-Term Debt	-	-	-	-	0.69
Long-Term Deferred Tax Liabilities	-	-	-	-	3
Other Long-Term Liabilities	0.55	0.48	1.22	0.26	8.44
Total Liabilities	2.16	3.26	6.05	1.34	14.19
Common Stock	0.07	0.07	6.24	5.82	5.42
Additional Paid-In Capital	9.76	9.76	8.14	6.9	6.4
Retained Earnings	-11.07	-10.92	-16.6	-14.02	-3.66
Comprehensive Income & Other	-	-	-0.03	-	-0.18
Shareholders' Equity	-1.24	-1.09	-2.25	-1.3	7.98
Total Liabilities & Equity	0.92	2.17	3.8	0.05	22.17
Total Debt	-	-	-	-	1.22
Net Cash (Debt)	-	-	0.01	-	-0.96
Net Cash Per Share	-	-	0.00	-	-0.03
Filing Date Shares Outstanding	143.42	143.53	117.93	109.93	102.35
Total Common Shares Outstanding	143.42	143.53	117.93	109.93	102.35
Working Capital	-1.61	-2.27	-4.42	-1.04	-0.99
Book Value Per Share	-0.01	-0.01	-0.02	-0.01	0.08
Tangible Book Value	-1.24	-1.09	-3.89	-1.3	-2.88
Tangible Book Value Per Share	-0.01	-0.01	-0.03	-0.01	-0.03
Machinery	-	-	-	-	2.36

Source: S&P Global Market Intelligence. Standard template. Financial Sources.